Stuart Walter Peltz - Insider Trading Tracker

Introduction

This page provides a comprehensive analysis of the known insider trading history of Stuart Walter Peltz. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

Companies with Reported Insider Positions

The SEC filings indicate Stuart Walter Peltz has reported holdings or trades in the following companies:

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Stuart Walter Peltz. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases OBIO / Orchestra BioMed Holdings, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in OBIO / Orchestra BioMed Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales OBIO / Orchestra BioMed Holdings, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in OBIO / Orchestra BioMed Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Purchases PTCT / PTC Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in OBIO / Orchestra BioMed Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales PTCT / PTC Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in OBIO / Orchestra BioMed Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2023-01-31	PTCT	Peltz Stuart Walter	2,320	45.6280	2,320	45.6280	105,857	275	18.0700	-63,934	-60.40
2023-01-31	PTCT	Peltz Stuart Walter	301	45.6280	301	45.6280	13,734
2023-01-24	PTCT	Peltz Stuart Walter	284	47.4513	284	47.4513	13,476
2023-01-11	PTCT	Peltz Stuart Walter	1,189	44.3596	1,189	44.3596	52,744
2023-01-11	PTCT	Peltz Stuart Walter	492	44.3596	492	44.3596	21,825
2023-01-10	PTCT	Peltz Stuart Walter	1,228	42.9329	1,228	42.9329	52,722
2023-01-10	PTCT	Peltz Stuart Walter	571	42.9329	571	42.9329	24,515
2023-01-09	PTCT	Peltz Stuart Walter	1,786	41.6562	1,786	41.6562	74,398
2023-01-09	PTCT	Peltz Stuart Walter	279	41.6562	279	41.6562	11,622
2022-06-07	PTCT	Peltz Stuart Walter	407	26.8280	407	26.8280	10,919
2022-04-14	PTCT	Peltz Stuart Walter	82	45.2790	82	45.2790	3,713
2022-02-01	PTCT	Peltz Stuart Walter	1,961	40.0020	1,961	40.0020	78,444
2022-02-01	PTCT	Peltz Stuart Walter	282	40.0020	282	40.0020	11,281
2022-01-25	PTCT	Peltz Stuart Walter	330	39.3140	330	39.3140	12,974
2022-01-07	PTCT	Peltz Stuart Walter	1,869	38.5250	1,869	38.5250	72,003
2022-01-07	PTCT	Peltz Stuart Walter	294	38.5250	294	38.5250	11,326
2022-01-04	PTCT	Peltz Stuart Walter	378	41.1620	378	41.1620	15,559
2021-02-01	PTCT	Peltz Stuart Walter	1,968	56.9560	1,968	56.9560	112,089
2021-02-01	PTCT	Peltz Stuart Walter	283	56.9560	283	56.9560	16,119
2021-01-25	PTCT	Peltz Stuart Walter	350	62.0540	350	62.0540	21,719
2021-01-05	PTCT	Peltz Stuart Walter	1,402	62.3700	1,402	62.3700	87,443
2021-01-05	PTCT	Peltz Stuart Walter	284	62.3700	284	62.3700	17,713
2021-01-05	PTCT	Peltz Stuart Walter	382	62.3700	382	62.3700	23,825
2020-01-23	PTCT	Peltz Stuart Walter	423	53.2470	423	53.2470	22,523
2020-01-06	PTCT	Peltz Stuart Walter	1,797	48.1680	1,797	48.1680	86,558
2020-01-06	PTCT	Peltz Stuart Walter	439	48.1680	439	48.1680	21,146
2020-01-06	PTCT	Peltz Stuart Walter	359	48.1680	359	48.1680	17,292
2019-01-07	PTCT	Peltz Stuart Walter	1,764	34.7500	1,764	34.7500	61,299
2019-01-07	PTCT	Peltz Stuart Walter	339	34.7500	339	34.7500	11,780
2019-01-07	PTCT	Peltz Stuart Walter	409	34.7500	409	34.7500	14,213
2018-01-05	PTCT	Peltz Stuart Walter	2,230	18.0300	2,230	18.0300	40,207

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Stuart Walter Peltz as disclosed to the Securities Exchange Commission (SEC).